We consider Riemannian manifolds endowed with a nonholonomic distribution. These structures model mechanical systems with a (positive definite) quadratic Lagrangian and nonholonomic constraints linear in velocities. We classify the left-invariant nonholonomic Riemannian structures on threedimensional simply connected Lie groups, and describe the equivalence classes in terms of some basic isometric invariants. The classification naturally splits into two cases. In the first case, it reduces to a classification of left-invariant sub-Riemannian structures. In the second case, we find a canonical frame with which to directly compare equivalence classes.
We construct the concrete category LiCS of left-invariant control systems (on Lie groups) and point out some very basic properties. Morphisms in this category are examined briefly. Also, covering control systems are introduced and organized into a (comma) category associated with LiCS
Any two-input left-invariant control affine system of full rank, evolving on the Euclidean group SE (2), is (detached) feedback equivalent to one of three typical cases. In each case, we consider an optimal control problem which is then lifted, via the Pontryagin Maximum Principle, to a Hamiltonian system on the dual space se (2) *. These reduced Hamilton−Poisson systems are the main topic of this paper. A qualitative analysis of each reduced system is performed. This analysis includes a study of the stability nature of all equilibrium states, as well as qualitative descriptions of all integral curves. Finally, the reduced Hamilton equations are explicitly integrated by Jacobi elliptic functions. Parametrisations for all integral curves are exhibited.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.